Biognosys Immunopeptidome Profiling Solution for MHC Class I And Class II Neoantigens Discovery in Tumor Biopsies - Case Study - Biognosys

Biognosys Immunopeptidome Profiling Solution for MHC Class I And Class II Neoantigens Discovery in Tumor Biopsies – Case Study

Case Studies

The case study elaborates on the latest study on lung cancer we performed with our high-throughput TrueDiscovery™ platform for immunopeptidome profiling from needle-sized biopsies. We identified > 11,000 Class I and > 9,000 Class II immunopeptides on average.

Back to Resources overview

Helpdesk

Access our knowledge base with relevant resources and guiding information.

Contact

    Close banner

    New: Spectronaut® 17

    A Groundbreaking Increase in Identifications

    New: Spectronaut® 17

    A Groundbreaking Increase in Identifications

    Learn More